feed,title,long_url,short_url
Benzinga,"Passage Bio To Cut Workforce, Prioritize R&D Programs To Reduce Operating Expenses",https://benzinga.com/general/biotech/22/03/26144538/passage-bio-to-cut-workforce-prioritize-r-d-programs-to-reduce-operating-expenses,https://bit.ly/3KJu6CG
Benzinga,Better Therapeutics' Diabetes Digital Therapeutic Shows Better Glycemic Control Vs. Standard Care,https://benzinga.com/general/biotech/22/03/26144916/better-therapeutics-diabetes-digital-therapeutic-shows-better-glycemic-control-vs-standard-care,https://bit.ly/3tUk8HQ
